Otsuka and Click Therapeutics’ Rejoyn has become the first prescription digital therapeutic (DTx) to be approved by the FDA for people with major depressive disorder. Rejoyn (formerly CT-152), a ...
Sweden's Vicore Pharma has started a clinical trial of a digital therapeutic (DTx) intended to relieve anxiety in patients with idiopathic pulmonary fibrosis (IPF), a debilitating and progressive ...
DTx Pharma, Inc., a privately held biotechnology company located in San Diego, CA, and founded in 2018, has developed a proprietary technology platform to enable the delivery of novel RNA-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback